Level Biotechnology Inc. (TPEX:3118)
Taiwan
· Delayed Price · Currency is TWD 33.25
0.00 (0.00%)
At close: Mar 10, 2026
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 1.08 billion as of March 10, 2026. Its market cap has increased by 3.91% in one year.
Market Cap
1.08B
Enterprise Value
876.70M
Revenue
736.59M
Ranking
n/a
PE Ratio
13.63
Stock Price
33.25
Market Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 1.08B, an increase of 332.17%. That is a compound annual growth rate of 7.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.10B |
| Lukas Biomedical | 1.12B |
| GeneReach Biotechnology | 1.17B |
| Taiwan Advance Bio-Pharmaceutical | 958.50M |
| TCI GENE | 949.86M |
| NatureWise Biotech & Medicals | 940.05M |
| Enimmune | 1.27B |
| Neith | 899.73M |